(Q36145795)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Charlie Strange

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Dean E Schraufnagel

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Robert Simms

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Robert A. Wise

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Donald P Tashkin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Philip J Clements

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Michael D Roth

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Daniel E Furst

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Richard M Silver

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Edgar Arriola

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Marcy B Bolster

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

James R Seibold

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

David J Riley

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Vivien M Hsu

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

John Varga

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Arthur Theodore

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Fred Wigley

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Barbara White

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Virginia Steen

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Charles Read

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Maureen Mayes

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Ed Parsley

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Kamal Mubarak

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

M Kari Connolly

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Jeffrey Golden

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Mitchell Olman

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Barri Fessler

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Naomi Rothfield

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Mark Metersky

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Dinesh Khanna

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Ning Li

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Gang Li

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Scleroderma Lung Study Research Group

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Robert Elashoff

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

language of work or name

English

0 references

publication date

23 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Respiratory and Critical Care Medicine

3 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

1026-1034

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

3 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

An approach to joint analysis of longitudinal measurements and competing risks failure time data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

Cyclophosphamide versus placebo in scleroderma lung disease.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

Mechanisms and Measurement of Dyspnea in Chronic Obstructive Pulmonary Disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

Pathophysiology of dyspnea

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

Standardization of Spirometry, 1994 Update. American Thoracic Society

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

Effects of cyclophosphamide on the development of malignancy and on long‐term survival of patients with rheumatoid arthritis a 20‐year followup study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

Reference spirometric values using techniques and equipment that meet ATS recommendations

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

Standardized single breath normal values for carbon monoxide diffusing capacity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

Severe restrictive lung disease in systemic sclerosis.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2078679

Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung

23 September 2018

1 reference

12 December 2020

A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease

1 reference

12 December 2020

Cyclophosphamide for scleroderma lung disease

1 reference

12 December 2020

American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update

1 reference

12 December 2020

Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis

1 reference

12 December 2020

The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes

1 reference

12 December 2020

Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease

1 reference

12 December 2020

Guidelines for the measurement of respiratory function. Recommendations of the British Thoracic Society and the Association of Respiratory Technicians and Physiologists

1 reference

12 December 2020

Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study

1 reference

12 December 2020

AARC clinical practice guideline. Body plethysmography. American Association for Respiratory Care

1 reference

12 December 2020

Robust Regression: Asymptotics, Conjectures and Monte Carlo

1 reference

19 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1214/AOS/1176342503

Identifiers

DOI

10.1164/RCCM.200702-326OC

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17717203%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

PubMed publication ID

17717203

1 reference